Novel Agents and Combinations in Hodgkin Lymphoma

0 意见
administrator
administrator
07/09/23

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个